This inventor holds 1 USPTO granted patent. Top assignee: Health Research, Inc.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Li Tang in Bladder Cancer Therapy
Introduction
Li Tang is an innovative inventor based in Lancaster, NY (US). He has made significant contributions to the field of cancer therapy, particularly focusing on bladder cancer. His work emphasizes the use of natural compounds for therapeutic purposes, showcasing the potential of nutraceuticals in modern medicine.
Latest Patents
Li Tang holds a patent for a method related to the delivery and use of isothiocyanates for the prophylaxis and/or therapy of bladder cancer. The patent describes a composition that includes a mixture of broccoli seed and mustard seed. The broccoli seed undergoes a baking process at a temperature of at least 200 degrees Fahrenheit for a minimum of 60 minutes, followed by a pressurized heat treatment at the same temperature and a pressure of at least 10 pounds per square inch for at least 5 minutes. This innovative method aims to inhibit the growth and recurrence of bladder cancer through the oral administration of isothiocyanates or their derivatives.
Career Highlights
Li Tang is associated with Health Research, Inc., where he continues to explore the therapeutic applications of natural compounds. His research is pivotal in advancing the understanding of how certain dietary components can play a role in cancer prevention and treatment.
Collaborations
Li Tang collaborates with notable colleagues, including Yuesheng Zhang and Joseph D Paonessa. Their combined expertise contributes to the ongoing research and development of effective cancer therapies.
Conclusion
Li Tang's innovative approach to bladder cancer therapy through the use of isothiocyanates highlights the importance of natural compounds in medical research. His contributions are paving the way for new therapeutic strategies that could significantly impact cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile